3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
555
Triple Negative Breast Neoplasms
94
Inflammatory Breast Neoplasms
38
Breast Neoplasms, Male
31
Neoplasm Metastasis
27
Ovarian Neoplasms
25
Carcinoma, Non-Small-Cell Lung
23
Melanoma
21
Pancreatic Neoplasms
14
Neoplasms
14
Colorectal Neoplasms
13
Carcinoma, Renal Cell
12
Stomach Neoplasms
11
Multiple Myeloma
10
Lung Neoplasms
10
Carcinoma, Ovarian Epithelial
9
Carcinoma, Hepatocellular
9
Lymphoma, Non-Hodgkin
8
Sarcoma
7
Lymphoma, Follicular
7
Lymphoma
7
Carcinoma, Ductal, Breast
7
Recurrence
6
Neutropenia
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, B-Cell, Marginal Zone
6
Leukemia, Myeloid, Acute
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
rebastinib
1
pembrolizumab
1
ceralasertib
1
belinostat
1
X-Rays
1
Paclitaxel
1
Nivolumab
1
Immunoglobulin G
1
Fluorouracil
1
DCC-2036
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Cyclophosphamide
×
Breast
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled